Enhanced secretion of IFN-γ by activated Th1 cells occurs via reverse signaling through TNF-related activation-induced cytokine

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 270-276

  Chen, N J ^a   Huang, M W ^a   Hsieh, S L ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOGLOBULIN PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL;

EID: 0035167691     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.270     Document Type: Article

References (39)

1. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
2. TRANCE (tumor necrosis factor (TNF)-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
3. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
4. TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo
5. Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development
6. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
7. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
8. TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells
9. + T lymphocytes
10. CD40 ligand-transduced co-stimulation of T cells in the development of helper function
11. + T cell activation response that resuhs in secretion of immunomodulatory cytokines and apoptosis
12. Reverse signaling via CD30 ligand
13. Aberrant expression and reverse signaling of CD70 on malignant B cells
14. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand
15. + T cells
16. CD137 induces proliferation and endomitosis in monocytes
17. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells
18. LIGHT, a novel ligand for lymphotoxin β receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer
19. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin-10 in interferon-γ and in interleukin-4-expressing cells
20. IL-12 regulates T helper type 1 cytokine responses in human infectious disease
21. Cloning of a new cytokine that induces IFN-γ production by T cells
22. A soluble factor produced by lamina propria mononuclear cells is required for enhancement of IFN-γ production by T cells
23. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
24. T cell proliferation m response to interleukins 2 and 7 requires p38MAP kinase activation
25. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-α production in a manner distinct from LPS activation of monocytes
26. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway
27. A casein kinase I motif present in the cytoplasmic domain of members of the tumor necrosis factor ligand family is implicated in "reverse signaling."
28. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
29. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL:
30. The receptor for the cytotoxic ligand TRAIL
31. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
32. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
33. A novel receptor for Apo2L/TRAIL contains a truncated death domain
34. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
35. Apoptosis control by death and decoy receptors
36. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
37. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
38. Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages
39. TNF-induced shedding of TNF receptors in human polymorphonuclear leukocytes: Role of the 55-kDa TNF receptor and involvement of a membrane-bound and non-matrix metalloproteinase